CELU logo

Celularity Inc. Class A Common Stock


CELU: Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.


Show CELU Financials

Consumer Interest
SEC Filings

Recent trades of CELU by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by CELU's directors and management

Government lobbying spending instances

  • $10,000 Jul 18, 2023 Issue: Health Issues
  • $10,000 Apr 19, 2023 Issue: Health Issues
  • $10,000 Jan 17, 2023 Issue: Health Issues
  • $10,000 Oct 19, 2022 Issue: Health Issues
  • $10,000 Jul 19, 2022 Issue: Health Issues
  • $10,000 Apr 19, 2022 Issue: Health Issues
  • $10,000 Jan 19, 2022 Issue: Health Issues
  • $10,000 Oct 19, 2021 Issue: Health Issues
  • $10,000 Jul 19, 2021 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of CELU in WallStreetBets Daily Discussion


Recent insights relating to CELU

CNBC Recommendations

Recent picks made for CELU stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CELU

Corporate Flights

Flights by private jets registered to CELU